A 32-year-old Medtronic sales representative was killed last week in an apparently random shooting in San Francisco, according to news reports. Kathryn Steinle was walking along the waterfront of the Embarcadero in San Francisco with her father and a friend July 1 when she was shot in the chest, allegedly by Francisco Sanchez, a convicted felon […]
Medtronic
Medtronic touts 1-year data for VenaSeal device
Medtronic (NYSE:MDT) today touted results from its VeClose clinical trial of its VenaSeal varicose vein treatment, saying the device posted a 96.8% closure rate at 12 months. Results from the study were presented by principal investigator Dr. Nick Morrison of the Morrison Vein Institute in Scottsdale, Ariz., at the the European Venous Forum 2015 in St. Petersburg, Russia. VenaSeal […]
TAVI: Medtronic wins patent spat with doc inventor
Medtronic (NYSE:MDT) last week won a patent infringement dispute over its CoreValve aortic valve replacement with inventor Dr. Troy Norred, according to legal filings. The U.S. Patent & Trademark Office’s Patent Trial & Appeals Board found that 16 of Norred’s claims were unpatentable, upholding Medtronic’s challenge to the patent, PTO records show. The patent board ruled that […]
Medtronic wins FDA nod, launches Advisa SR MRI-safe pacer
Medtronic (NYSE:MDT) said today that it won FDA approval for its Advisa SR MRI-safe SureScan single-chamber pacemaker, and that it is launching the device in the U.S. The device will allow MRI scans of any region of the body as long as it is used with MRI-safe SureScan leads, the Fridley, Minn.-based company said. “MRI is […]
Medtronic shuffles the deck | Personnel Moves
Medtronic (NYSE:MDT) today said it named Geoff Martha to be the new president of its restorative therapies division, replacing Christopher O’Connell, who left to take the CEO spot at Waters Corp. Martha is slated to be replaced in the chief integration officer role by Bill Burke, who joined Medtronic as part of its $50 billion acquisition […]
Medtronic’s Covidien to put pelvic mesh cases to bed
(Reuters) —Medtronic‘s (NYSE:MDT) Covidien unit has agreed to settle some of the more than 11,000 claims involving its transvaginal mesh devices, which patients allege caused severe and painful side effects, according to a court filing. The filing on Tuesday in West Virginia federal court did not disclose the amount of the settlement nor how many cases […]
Medtronic recalls Covidien Shiley tracheostomy tubes
Medtronic (NYSE:MDT) said today that it is recalling certain lots of its Covidien Shiley tracheostomy tubes after receiving complaints and reports of serious injury. The company said it began notifying hospitals and distributors worldwide on May 8 of the issue. The recalled tracheostomy tubes, manufactured after November 29, 2012, were formed with a wider-angle bend than […]
TAVI: FDA approves Medtronic’s CoreValve Evolut R
Medtronic (NYSE:MDT) said today that the FDA granted pre-market approval for its CoreValve Evolut R replacement heart valve, less than a week after approving the competing Sapien 3 valve made by Edwards Lifesciences (NYSE:EW). The devices are 3rd-generation transcatheter aortic valve implants designed to treat leaky heart valves. Both the CoreValve Evolut R and the Sapien 3 are […]
Medtronic touts 5-year Endurant AAA stent data
Medtronic (NYSE:MDT) said its Endurant abdominal aortic aneurysm stent is performing well, according to a 5-year follow-up study of the device. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago last Saturday. The 5-year, 150-patient study data reported a 99.2% freedom from aneurysm related mortality and an 89% freedom from secondary […]
Two a day: Medtronic acquires Aptus Endo for $110m
Medtronic (NYSE:MDT) announced its 2nd acquisition of the day this afternoon, saying it paid $110 million to acquire Aptus Endosystems and its Heli-FX device aortic securement device. Earlier today the Fridley, Minn.-based medical device giant said it picked up CardioInsight for $93 million. “We are excited to add this unique complementary, anchor technology to our aortic portfolio,” aortic […]
Medtronic puts up $93m for CardioInsight
Medtronic (NYSE:MDT) said today that it paid $93 million for CardioInsight Technologies and its heart-mapping technology. Cleveland-based CardioInsight makes the ECVue, a non-invasive electrocardiographic mapping device that uses body surface electrical data and anatomical data to reconstruct and display 3-D maps and “other useful measures” of the heart’s electrical activity, Medtronic said. The deal includes a $75 million cash payment and a $25 million loan, according […]
